SG Americas Securities’s BioSpecifics Technologies Corp. BSTC Stock Holding History

SG Americas Securities’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,753	Closed	-$230K	–	3790
2020 Q2	$230K	Buy	3,753 +1,559	+71%	+$90.2K	﹤0.01%	2743
2020 Q1	$124K	Buy	+2,194	New	+$125K	﹤0.01%	2840
2019 Q4	–	Sell	-12,052	Closed	-$645K	–	3516
2019 Q3	$645K	Buy	+12,052	New	+$702K	0.01%	1710
2018 Q1	–	Sell	-6,911	Closed	-$299K	–	3674
2017 Q4	$299K	Buy	6,911 +3,438	+99%	+$155K	﹤0.01%	2178
2017 Q3	$162K	Sell	3,473 -1,386	-29%	-$66.4K	﹤0.01%	2773
2017 Q2	$241K	Buy	+4,859	New	+$255K	﹤0.01%	2292
2014 Q3	–	Sell	-5,304	Closed	-$143K	–	2912
2014 Q2	$143K	Buy	+5,304	New	+$138K	﹤0.01%	2201

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

SG Americas Securities's BSTC Position: Q3 2020 in Review

SG Americas Securities sold out of BioSpecifics Technologies Corp. (BSTC) in Q3 2020, closing a stake of 3,753 shares — an estimated $230K sold.

SG Americas Securities first reported a position in BSTC in Q2 2014 and held it in 7 quarters. The position peaked at $645K in Q3 2019. 113 funds tracked by Wall St. Rank hold BSTC as of Q3 2020.

SG Americas Securities reported no remaining BioSpecifics Technologies Corp. position as of Q3 2020 after selling out during the quarter.
SG Americas Securities sold 3,753 BioSpecifics Technologies Corp. shares in Q3 2020, an estimated $230K.
SG Americas Securities first reported a position in BioSpecifics Technologies Corp. in Q2 2014 and held it in 7 quarters.
SG Americas Securities's BioSpecifics Technologies Corp. position peaked at $645K in Q3 2019.
113 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2020.

Based on SG Americas Securities's 13F filing for Q3 2020, filed 9 Nov 2020.